The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maciaszek, J.
Right arrow Articles by Viglianti, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maciaszek, J.
Right arrow Articles by Viglianti, G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Substance via MeSH

The Journal of Immunology, Vol 158, Issue 1 5-8, Copyright © 1997 by American Association of Immunologists


CUTTING EDGE

IL-16 represses HIV-1 promoter activity

JW Maciaszek, NA Parada, WW Cruikshank, DM Center, H Kornfeld and GA Viglianti
The Program in Virology and Immunology, University of Massachusetts Medical Center, Worcester 01605, USA.

IL-16 is produced by CD8+ lymphocytes and has been reported to inhibit HIV-1 and SIV replication in infected PBMCs. CD4 serves as a receptor for the secreted form of IL-16, and IL-16 binding to CD4 induces signal transduction, which affects the activation state of the cell. We hypothesized, therefore, that the effect of IL-16 on HIV-1 replication might occur at the level of virus expression. In transient transfection studies with HIV-1 LTR-reporter gene constructs we found that pretreatment of CD4+ lymphoid cells with recombinant IL-16 repressed HIV-1 promoter activity up to 60-fold, preventing both PMA and Tat activation. This effect of IL-16 required sequences contained within the core enhancer, but was not simply due to the down-regulation of transcription factors binding to this element.


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. D. Mannie and D. J. Abbott
A Fusion Protein Consisting of IL-16 and the Encephalitogenic Peptide of Myelin Basic Protein Constitutes an Antigen-Specific Tolerogenic Vaccine That Inhibits Experimental Autoimmune Encephalomyelitis
J. Immunol., August 1, 2007; 179(3): 1458 - 1465.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. C. Qi, J. Wang, S. Mandadi, K. Tanaka, B. D. Roufogalis, M. C. Madigan, K. Lai, F. Yan, B. H. Chong, R. L. Stevens, et al.
Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor
Blood, January 1, 2006; 107(1): 135 - 142.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. M. Archin, L. van den Boom, L. Perelygina, J. M. Hilliard, and S. S. Atherton
Delayed Spread and Reduction in Virus Titer after Anterior Chamber Inoculation of a Recombinant of HSV-1 Expressing IL-16
Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3066 - 3076.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. C. Qi, R. L. Stevens, R. Wadley, A. Collins, M. Cooley, H. M. Naif, N. Nasr, A. Cunningham, G. Katsoulotos, Y. Wanigasek, et al.
IL-16 Regulation of Human Mast Cells/Basophils and Their Susceptibility to HIV-1
J. Immunol., April 15, 2002; 168(8): 4127 - 4134.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. D. Cristillo and B. E. Bierer
Identification of Novel Targets of Immunosuppressive Agents by cDNA-based Microarray Analysis
J. Biol. Chem., February 1, 2002; 277(6): 4465 - 4476.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Majka, A. Janowska-Wieczorek, J. Ratajczak, K. Ehrenman, Z. Pietrzkowski, M. A. Kowalska, A. M. Gewirtz, S. G. Emerson, and M. Z. Ratajczak
Numerous growth factors, cytokines, and chemokines are secreted by human CD34+ cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner
Blood, May 15, 2001; 97(10): 3075 - 3085.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. C. A. Darcissac, M.-J. Truong, J. Dewulf, Y. Mouton, A. Capron, and G. M. Bahr
The Synthetic Immunomodulator Murabutide Controls Human Immunodeficiency Virus Type 1 Replication at Multiple Levels in Macrophages and Dendritic Cells
J. Virol., September 1, 2000; 74(17): 7794 - 7802.
[Abstract] [Full Text]


Home page
BloodHome page
T. Yoshimoto, C.-R. Wang, T. Yoneto, A. Matsuzawa, W. W. Cruikshank, and H. Nariuchi
Role of IL-16 in delayed-type hypersensitivity reaction
Blood, May 1, 2000; 95(9): 2869 - 2874.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
I Sekigawa, S Lee, H Kaneko, N Iida, H Hashimoto, S Hirose, and Y Kaneko
The possible role of interleukin-16 in the low incidence of HIV infection in patients with systemic lupus erythematosus
Lupus, February 1, 2000; 9(2): 155 - 156.
[PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. KOZIEL, S. KIM, C. REARDON, X. LI, R. GARLAND, P. PINKSTON, and H. KORNFELD
Enhanced In Vivo Human Immunodeficiency Virus-1 Replication in the Lungs of Human Immunodeficiency Virus-Infected Persons with Pneumocystis carinii Pneumonia
Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 2048 - 2055.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
J. Nicoll, W. W. Cruikshank, W. Brazer, Y. Liu, D. M. Center, and H. Kornfeld
Identification of Domains in IL-16 Critical for Biological Activity
J. Immunol., August 15, 1999; 163(4): 1827 - 1832.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M.-J. Truong, E. C. A. Darcissac, E. Hermann, J. Dewulf, A. Capron, and G. M. Bahr
Interleukin-16 Inhibits Human Immunodeficiency Virus Type 1 Entry and Replication in Macrophages and in Dendritic Cells
J. Virol., August 1, 1999; 73(8): 7008 - 7013.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
P. Zhou, K. Devadas, D. Tewari, A. Jegorow, and A. L. Notkins
Processing, Secretion, and Anti-HIV-1 Activity of IL-16 With or Without a Signal Peptide in CD4+ T Cells
J. Immunol., July 15, 1999; 163(2): 906 - 912.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. K. Sharma, J. Trujillo, H.-F. Song, F. P. Saitta, O. B. Laeyendecker, R. Castillo, S. Arango-Jaramillo, G. Sridharan, M. Dettenhofer, K. Blakemore, et al.
A Novel Factor Produced by Placental Cells with Activity Against HIV-1
J. Immunol., December 1, 1998; 161(11): 6406 - 6412.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. L. Chupp, E. A. Wright, D. Wu, M. Vallen-Mashikian, W. W. Cruikshank, D. M. Center, H. Kornfeld, and J. S. Berman
Tissue and T Cell Distribution of Precursor and Mature IL-16
J. Immunol., September 15, 1998; 161(6): 3114 - 3119.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. A. Van Baalen, M. Schutten, R. C. Huisman, P. H. M. Boers, R. A. Gruters, and A. D. M. E. Osterhaus
Kinetics of Antiviral Activity by Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes (CTL) and Rapid Selection of CTL Escape Virus In Vitro
J. Virol., August 1, 1998; 72(8): 6851 - 6857.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Keane, J. Nicoll, S. Kim, D. M. H. Wu, W. W. Cruikshank, W. Brazer, B. Natke, Y. Zhang, D. M. Center, and H. Kornfeld
Conservation of Structure and Function Between Human and Murine IL-16
J. Immunol., June 15, 1998; 160(12): 5945 - 5954.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Zhang, H. Kornfeld, W. W. Cruikshank, S. Kim, C. C. Reardon, and D. M. Center
Nuclear Translocation of the N-terminal Prodomain of Interleukin-16
J. Biol. Chem., January 5, 2001; 276(2): 1299 - 1303.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.